Literature DB >> 29875317

NaV1.1 inhibition can reduce visceral hypersensitivity.

Juan Salvatierra1, Joel Castro2,3, Andelain Erickson2,3, Qian Li4, Joao Braz5, John Gilchrist1, Luke Grundy2,3, Grigori Y Rychkov2,3, Annemie Deiteren2,3, Rana Rais6, Glenn F King7, Barbara S Slusher6, Allan Basbaum5, Pankaj J Pasricha4, Stuart M Brierley2,3, Frank Bosmans1,8.   

Abstract

Functional bowel disorder patients can suffer from chronic abdominal pain, likely due to visceral hypersensitivity to mechanical stimuli. As there is only a limited understanding of the basis of chronic visceral hypersensitivity (CVH), drug-based management strategies are ill defined, vary considerably, and include NSAIDs, opioids, and even anticonvulsants. We previously reported that the 1.1 subtype of the voltage-gated sodium (NaV; NaV1.1) channel family regulates the excitability of sensory nerve fibers that transmit a mechanical pain message to the spinal cord. Herein, we investigated whether this channel subtype also underlies the abdominal pain that occurs with CVH. We demonstrate that NaV1.1 is functionally upregulated under CVH conditions and that inhibiting channel function reduces mechanical pain in 3 mechanistically distinct mouse models of chronic pain. In particular, we use a small molecule to show that selective NaV1.1 inhibition (a) decreases sodium currents in colon-innervating dorsal root ganglion neurons, (b) reduces colonic nociceptor mechanical responses, and (c) normalizes the enhanced visceromotor response to distension observed in 2 mouse models of irritable bowel syndrome. These results provide support for a relationship between NaV1.1 and chronic abdominal pain associated with functional bowel disorders.

Entities:  

Keywords:  Gastroenterology; Ion channels; Neuroscience; Pain

Mesh:

Substances:

Year:  2018        PMID: 29875317      PMCID: PMC6124407          DOI: 10.1172/jci.insight.121000

Source DB:  PubMed          Journal:  JCI Insight        ISSN: 2379-3708


  48 in total

1.  The phenotype of congenital insensitivity to pain due to the NaV1.9 variant p.L811P.

Authors:  Christopher Geoffrey Woods; Mohamed Osman Eltahir Babiker; Iain Horrocks; John Tolmie; Ingo Kurth
Journal:  Eur J Hum Genet       Date:  2015-10       Impact factor: 4.246

Review 2.  Voltage-gated sodium channels: (NaV )igating the field to determine their contribution to visceral nociception.

Authors:  Andelain Erickson; Annemie Deiteren; Andrea M Harrington; Sonia Garcia-Caraballo; Joel Castro; Ashlee Caldwell; Luke Grundy; Stuart M Brierley
Journal:  J Physiol       Date:  2018-02-06       Impact factor: 5.182

Review 3.  Irritable bowel syndrome: a clinical review.

Authors:  William D Chey; Jacob Kurlander; Shanti Eswaran
Journal:  JAMA       Date:  2015-03-03       Impact factor: 56.272

4.  Transient receptor potential vanilloid-4 has a major role in visceral hypersensitivity symptoms.

Authors:  Nicolas Cenac; Christophe Altier; Kevin Chapman; Wolfgang Liedtke; Gerald Zamponi; Nathalie Vergnolle
Journal:  Gastroenterology       Date:  2008-05-10       Impact factor: 22.682

5.  Quantitative assessment of tactile allodynia in the rat paw.

Authors:  S R Chaplan; F W Bach; J W Pogrel; J M Chung; T L Yaksh
Journal:  J Neurosci Methods       Date:  1994-07       Impact factor: 2.390

6.  Effect of a second-generation alpha2delta ligand (pregabalin) on visceral sensation in hypersensitive patients with irritable bowel syndrome.

Authors:  L A Houghton; C Fell; P J Whorwell; I Jones; D P Sudworth; J D Gale
Journal:  Gut       Date:  2007-04-19       Impact factor: 23.059

Review 7.  The Role of Visceral Hypersensitivity in Irritable Bowel Syndrome: Pharmacological Targets and Novel Treatments.

Authors:  Mohammad H Farzaei; Roodabeh Bahramsoltani; Mohammad Abdollahi; Roja Rahimi
Journal:  J Neurogastroenterol Motil       Date:  2016-10-30       Impact factor: 4.924

8.  Discovery of 6-Diazo-5-oxo-l-norleucine (DON) Prodrugs with Enhanced CSF Delivery in Monkeys: A Potential Treatment for Glioblastoma.

Authors:  Rana Rais; Andrej Jančařík; Lukáš Tenora; Michael Nedelcovych; Jesse Alt; Judson Englert; Camilo Rojas; Anne Le; Amira Elgogary; Jessica Tan; Lenka Monincová; Kelly Pate; Robert Adams; Dana Ferraris; Jonathan Powell; Pavel Majer; Barbara S Slusher
Journal:  J Med Chem       Date:  2016-09-06       Impact factor: 7.446

9.  Case Report: Neuropathic pain in a patient with congenital insensitivity to pain.

Authors:  Daniel W Wheeler; Michael C H Lee; E Katherine Harrison; David K Menon; C Geoffrey Woods
Journal:  F1000Res       Date:  2014-06-26

10.  Selective spider toxins reveal a role for the Nav1.1 channel in mechanical pain.

Authors:  Jeremiah D Osteen; Volker Herzig; John Gilchrist; Joshua J Emrick; Chuchu Zhang; Xidao Wang; Joel Castro; Sonia Garcia-Caraballo; Luke Grundy; Grigori Y Rychkov; Andy D Weyer; Zoltan Dekan; Eivind A B Undheim; Paul Alewood; Cheryl L Stucky; Stuart M Brierley; Allan I Basbaum; Frank Bosmans; Glenn F King; David Julius
Journal:  Nature       Date:  2016-06-06       Impact factor: 49.962

View more
  12 in total

1.  Tetrodotoxin-Sensitive Sodium Channels Mediate Action Potential Firing and Excitability in Menthol-Sensitive Vglut3-Lineage Sensory Neurons.

Authors:  Theanne N Griffith; Trevor A Docter; Ellen A Lumpkin
Journal:  J Neurosci       Date:  2019-07-12       Impact factor: 6.167

2.  Pharmacological Inhibition of the Voltage-Gated Sodium Channel NaV1.7 Alleviates Chronic Visceral Pain in a Rodent Model of Irritable Bowel Syndrome.

Authors:  Yan Jiang; Joel Castro; Linda V Blomster; Akello J Agwa; Jessica Maddern; Gudrun Schober; Volker Herzig; Chun Yuen Chow; Fernanda C Cardoso; Paula Demétrio De Souza França; Junior Gonzales; Christina I Schroeder; Steffen Esche; Thomas Reiner; Stuart M Brierley; Glenn F King
Journal:  ACS Pharmacol Transl Sci       Date:  2021-06-07

Review 3.  The NaV1.7 Channel Subtype as an Antinociceptive Target for Spider Toxins in Adult Dorsal Root Ganglia Neurons.

Authors:  Tânia C Gonçalves; Evelyne Benoit; Michel Partiseti; Denis Servent
Journal:  Front Pharmacol       Date:  2018-09-04       Impact factor: 5.810

Review 4.  The Role of Toxins in the Pursuit for Novel Analgesics.

Authors:  Yossi Maatuf; Matan Geron; Avi Priel
Journal:  Toxins (Basel)       Date:  2019-02-23       Impact factor: 4.546

Review 5.  Structure-Function and Therapeutic Potential of Spider Venom-Derived Cysteine Knot Peptides Targeting Sodium Channels.

Authors:  Fernanda C Cardoso; Richard J Lewis
Journal:  Front Pharmacol       Date:  2019-04-11       Impact factor: 5.810

6.  Activation of pruritogenic TGR5, MrgprA3, and MrgprC11 on colon-innervating afferents induces visceral hypersensitivity.

Authors:  Joel Castro; Andrea M Harrington; TinaMarie Lieu; Sonia Garcia-Caraballo; Jessica Maddern; Gudrun Schober; Tracey O'Donnell; Luke Grundy; Amanda L Lumsden; Paul Miller; Andre Ghetti; Martin S Steinhoff; Daniel P Poole; Xinzhong Dong; Lin Chang; Nigel W Bunnett; Stuart M Brierley
Journal:  JCI Insight       Date:  2019-10-17

7.  Voltage-Gated Sodium Channel Modulation by a New Spider Toxin Ssp1a Isolated From an Australian Theraphosid.

Authors:  Yashad Dongol; Phil M Choi; David T Wilson; Norelle L Daly; Fernanda C Cardoso; Richard J Lewis
Journal:  Front Pharmacol       Date:  2021-12-24       Impact factor: 5.810

8.  Design of a Stable Cyclic Peptide Analgesic Derived from Sunflower Seeds that Targets the κ-Opioid Receptor for the Treatment of Chronic Abdominal Pain.

Authors:  Edin Muratspahić; Nataša Tomašević; Johannes Koehbach; Leopold Duerrauer; Seid Hadžić; Joel Castro; Gudrun Schober; Spyridon Sideromenos; Richard J Clark; Stuart M Brierley; David J Craik; Christian W Gruber
Journal:  J Med Chem       Date:  2021-06-23       Impact factor: 7.446

Review 9.  Spider Knottin Pharmacology at Voltage-Gated Sodium Channels and Their Potential to Modulate Pain Pathways.

Authors:  Yashad Dongol; Fernanda Caldas Cardoso; Richard J Lewis
Journal:  Toxins (Basel)       Date:  2019-10-29       Impact factor: 4.546

Review 10.  Tetrodotoxin: A New Strategy to Treat Visceral Pain?

Authors:  Ana Campos-Ríos; Lola Rueda-Ruzafa; Salvador Herrera-Pérez; Paula Rivas-Ramírez; José Antonio Lamas
Journal:  Toxins (Basel)       Date:  2021-07-16       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.